Expression of angiopoietic factors in normal and type-I diabetes human placenta: A pilot study

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 111, Issue 2, 2003, Pages 153-156

  Janota, Jan ^a,b   Pomyje, Jiří ^b   Toth, Dušan ^b   Sosna, Ondřej ^b   Živný, Jaroslav ^b   Kužel, David ^b   Straňák, Zbyněk ^a   Nečas, Emanuel ^b   Živný, Jan H ^b  

^a INSTITUTE FOR THE CARE OF MOTHER AND CHILD   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Angiogenesis; Angiopoietin; Diabetes mellitus; Placenta; Vascular endothelial growth factor

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIUM; FEMALE; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; PILOT STUDY; PLACENTA; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

EID: 0242302308     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(03)00204-5     Document Type: Article

References (22)

1. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature. 407(6801):2000;249-257.
2. Asahara T., Masuda H., Takahashi T.et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 85(3):1999;221-228.
3. Patan S., Munn L.L., Jain R.K. Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc Res. 51(2):1996;260-272.
4. Casson I.F., Clarke C.A., Howard C.V.et al. Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ. 315(7103):1997;275-278.
5. Hadden D.R., Alexander A., McCance D.R., Traub A.I. Obstetric and diabetic care for pregnancy in diabetic women: 10 years outcome analysis, 1985-1995. Diabet Med. 18(7):2001;546-553.
6. Jirkovska M. Comparison of the thickness of the capillary basement membrane of the human placenta under normal conditions and in type 1 diabetes. Funct Dev Morphol. 1(3):1991;9-16.
7. Helske S., Vuorela P., Carpen O., Hornig C., Weich H., Halmesmaki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod. 7(2):2001;205-210.
8. Di Blasio A.M., Carniti C., Vigano P., Florio P., Petraglia F., Vignali M. Basic fibroblast growth factor messenger ribonucleic acid levels in human placentas from normal and pathological pregnancies. Mol Hum Reprod. 3(12):1997;1119-1123.
9. Brigino E., Haraguchi S., Koutsonikolis A.et al. Interleukin 10 is induced by recombinant HIV-1 Nef protein involving the calcium/calmodulin- dependent phosphodiesterase signal transduction pathway. Proc Natl Acad Sci USA. 94(7):1997;3178-3182.
10. Pomyje J., Zivny J.H., Stopka T., Simak J., Vankova H., Necas E. Angiopoietin-1, angiopoietin-2 and Tie-2 in tumour and non-tumour tissues during growth of experimental melanoma. Melanoma Res. 11(6):2001;639-643.
11. Tanaka S., Mori M., Sakamoto Y., Makuuchi M., Sugimachi K., Wands J.R. Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma. J Clin Invest. 103(3):1999;341-345.
12. Masood R., Cai J., Zheng T., Smith D.L., Naidu Y., Gill P.S. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA. 94(3):1997;979-984.
13. Risau W. Mechanisms of angiogenesis. Nature. 386(6626):1997;671-674.
14. Bailey E., Bottomley M.J., Westwell S.et al. Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation. J Clin Pathol. 52(10):1999;735-738.
15. Chou E., Suzuma I., Way K.J. Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: a possible explanation for impaired collateral formation in cardiac tissue. Circulation. 105(3):2002;373-379.
16. Joussen A.M., Poulaki V., Qin W.et al. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am J Pathol. 160(2):2002;501-509.
17. Kampfer H., Pfeilschifter J., Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest. 81(3):2001;361-373.
18. Isner J.M., Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. Clin Invest. 103(9):1999;1231-1236.
19. Cooper M.E., Vranes D., Youssef S., Stacker S.A., Cox A.J., Rizkalla B. et al. Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes. Diabetes. 48(11):1999;2229-2239.
20. Lerman O.Z., Galiano R.D., Armour M., Levine J.P., Gurtner G.C. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am J Pathol. 162(1):2003;303-312.
21. Jin K.L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA. 2997(18):2000;10242-10247.
22. Scott P.A., Gleadle J.M., Bicknell R., Harris A.L. Role of the hypoxia sensing system, acidity and reproductive hormones in the variability of vascular endothelial growth factor induction in human breast carcinoma cell lines. Int J Cancer. 275(5):1998;706-712.